Prescription drug · ANDA
ciprofloxacin NDC 71205-300
Ciprofloxacin hydrochloride 3 mg/mL · Solution · Ophthalmic · Proficient Rx LP
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 71205-300-05 | 71205030005 | 1 BOTTLE, PLASTIC in 1 CARTON (71205-300-05) / 5 mL in 1 BOTTLE, PLASTICMarketed from Nov 1, 2018 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- ciprofloxacin
- Generic name (nonproprietary)
- ciprofloxacin
- Active ingredients
- Ciprofloxacin hydrochloride — 3 mg/mL
- Dosage form
- Solution
- Route
- Ophthalmic
- Labeler
- Proficient Rx LP
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 077568
- Marketing start
- Listing expires
- Other FDA classes
- Quinolones (Chemical structure)
- Identifiers
- Product ID 71205-300_a797de06-c8be-4417-9bac-137dc4931c8bSPL ID a797de06-c8be-4417-9bac-137dc4931c8bSPL set ID 05b2836d-cd3d-4d7f-970c-66ec2d788667RxCUI 309307UNII 4BA73M5E37UPC 0371205300050
- Pharmacologic class
- Quinolone Antimicrobial
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Ophthalmic products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N471205030005followed by a unit qualifier and the quantityPackage 71205-0300-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Ciprofloxacin Ophthalmic Solution is indicated for the treatment of infections caused by susceptible strains of the designated microorganisms in the conditions listed below: Corneal Ulcers: Pseudomonas aeruginosa Serratia marcescens * Staphylococcus aureus Staphylococcus epidermidis Streptococcus pneumoniae Streptococcus (Viridans Group) * Conjunctivitis: Haemophilus influenzae Staphylococcus aureus Staphylococcus epidermidis Streptococcus pneumoniae *Efficacy for this organism was studied in fewer than 10 infections.
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 077568
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| ciprofloxacin | Ciprofloxacin hydrochloride 3 mg/mL | SolutionOphthalmic | Leading Pharma, LLC | 69315-308 |
| ciprofloxacin | Ciprofloxacin hydrochloride 3 mg/mL | SolutionOphthalmic | Advanced Rx of Tennessee, LLC | 80425-0499 |
| ciprofloxacin | Ciprofloxacin hydrochloride 3 mg/mL | SolutionOphthalmic | NuCare Pharmaceuticals,Inc. | 68071-4672 |
| ciprofloxacin | Ciprofloxacin hydrochloride 3 mg/mL | SolutionOphthalmic | NuCare Pharmaceuticals,Inc. | 68071-4679 |
| ciprofloxacin | Ciprofloxacin hydrochloride 3 mg/mL | SolutionOphthalmic | Preferred Pharmaceuticals, Inc. | 68788-7500 |
| ciprofloxacin | Ciprofloxacin hydrochloride 3 mg/mL | SolutionOphthalmic | Sportpharm LLC | 85766-023 |
| ciprofloxacin | Ciprofloxacin hydrochloride 3 mg/mL | SolutionOphthalmic | Redpharm Drug | 67296-1703 |
| ciprofloxacin | Ciprofloxacin hydrochloride 3 mg/mL | SolutionOphthalmic | A-S Medication Solutions | 50090-4217 |
| ciprofloxacin | Ciprofloxacin hydrochloride 3 mg/mL | SolutionOphthalmic | Asclemed USA, Inc. | 76420-588 |
| ciprofloxacin | Ciprofloxacin hydrochloride 3 mg/mL | SolutionOphthalmic | HAWAII REPACK, INC | 85534-0075 |